Cargando…

Knockdown of Salusin-β Improves Cardiovascular Function in Myocardial Infarction-Induced Chronic Heart Failure Rats

Salusin-β is a biologically active peptide with 20 amino acids that exerts several cardiovascular activity-regulating effects, such as regulating vascular endothelial function and the proliferation of vascular smooth muscle cells. However, the regulatory effects of salusin-β in myocardial infarction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yu, Pan, Yan, Wang, Xingxing, Chen, Aidong, Tang, Xinyu, Liu, Xuanxuan, Han, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373485/ https://www.ncbi.nlm.nih.gov/pubmed/34422210 http://dx.doi.org/10.1155/2021/8896226

Ejemplares similares

Improvement of Vascular Function by Knockdown of Salusin-β in Hypertensive Rats via Nitric Oxide and Reactive Oxygen Species Signaling Pathway
por: Pan, Yan, et al.
Publicado: (2021)

Salusin-β, a TOR2A gene product, promotes proliferation, migration, fibrosis, and calcification of smooth muscle cells and accelerates the imbalance of vasomotor function and vascular remodeling in monocrotaline-induced pulmonary hypertensive rats
por: Wang, Xingxing, et al.
Publicado: (2022)

Serum salusin-α and salusin-β levels in patients with psoriatic arthritis
por: Kobak, Senol, et al.
Publicado: (2022)

Silencing salusin-β attenuates cardiovascular remodeling and hypertension in spontaneously hypertensive rats
por: Ren, Xing-Sheng, et al.
Publicado: (2017)

Salusin-β is superior to salusin-α as a marker for evaluating coronary atherosclerosis
por: Wang, Yuxue, et al.
Publicado: (2020)

Salusin-β as a powerful endogenous antidipsogenic neuropeptide
por: Suzuki-Kemuriyama, Noriko, et al.
Publicado: (2016)

Salusins: Potential Use as a Biomarker for Atherosclerotic Cardiovascular Diseases
por: Sato, Kengo, et al.
Publicado: (2013)

A New Marker for Determining Cardiovascular Risk: Salusin Alpha
por: Yılmaz, Emre, et al.
Publicado: (2022)

Central blockade of salusin β attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats
por: Li, Hong-Bao, et al.
Publicado: (2015)

Salusin-β, but Not Salusin-α, Promotes Human Umbilical Vein Endothelial Cell Inflammation via the p38 MAPK/JNK-NF-κB Pathway
por: Zhou, Cheng-Hua, et al.
Publicado: (2014)

Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy
por: Zhao, Ming-Xia, et al.
Publicado: (2017)

Salusin-β Not Salusin-α Promotes Vascular Inflammation in ApoE-Deficient Mice via the I-κBα/NF-κB Pathway
por: Zhou, Cheng-Hua, et al.
Publicado: (2014)

Anti-inflammatory effect of salusin-β knockdown on LPS-activated alveolar macrophages via NF-κB inhibition and HO-1 activation
por: Chen, Sheng, et al.
Publicado: (2021)

Effects of Two Types of Moderate- and High-Intensity Interval Training on Serum Salusin-α and Salusin-β Levels and Lipid Profile in Women with Overweight/Obesity
por: Nazari, Maryam, et al.
Publicado: (2020)

Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population?
por: Kołakowska, Urszula, et al.
Publicado: (2014)

Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide
por: Fujimoto, Kazumi, et al.
Publicado: (2017)

Circulating Levels of Human salusin-β,a Potent Hemodynamic and Atherogenesis Regulator
por: Fujimoto, Kazumi, et al.
Publicado: (2013)

Identification of the salusin-β receptor using proteoliposomes embedded with endogenous membrane proteins
por: Shichiri, Masayoshi, et al.
Publicado: (2018)

Salusin beta, atherosclerosis, and coronary slow flow
por: Akıncı, Sinan, et al.
Publicado: (2020)

Current Knowledge of Selected Cardiovascular Biomarkers in Pediatrics: Kidney Injury Molecule-1, Salusin-α and -β, Uromodulin, and Adropin
por: Močnik, Mirjam, et al.
Publicado: (2022)

Correction: Circulating Levels of Human Salusin-β, a Potent Hemodynamic and Atherogenesis Regulator
por: Fujimoto, Kazumi, et al.
Publicado: (2013)

Trimethylamine N‐oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction
por: Zhou, Xiang, et al.
Publicado: (2020)

Salusin-β mediates tubular cell apoptosis in acute kidney injury: Involvement of the PKC/ROS signaling pathway
por: Lu, Qing-Bo, et al.
Publicado: (2019)

Relationship of serum salusin beta levels with coronary slow flow
por: Akyüz, Aydın, et al.
Publicado: (2019)

The Biomarkers for Acute Myocardial Infarction and Heart Failure
por: Wang, Xi-Ying, et al.
Publicado: (2020)

Macrophage Activities in Myocardial Infarction and Heart Failure
por: Duncan, Sophia Esi, et al.
Publicado: (2020)

Mechanism of heart failure after myocardial infarction
por: Jiang, Huaiyu, et al.
Publicado: (2023)

Association between Functional Variables and Heart Failure after Myocardial Infarction in Rats
por: Polegato, Bertha F., et al.
Publicado: (2016)

Proteomics of acute heart failure in a rat post-myocardial infarction model
por: Guo, Yichen, et al.
Publicado: (2017)

Salusin-β in Intermediate Dorsal Motor Nucleus of the Vagus Regulates Sympathetic-Parasympathetic Balance and Blood Pressure
por: Wu, Lu-Lu, et al.
Publicado: (2021)

Knockdown of ZFAS1 improved the cardiac function of myocardial infarction rats via regulating Wnt/β-catenin signaling pathway
por: Zou, Bing, et al.
Publicado: (2021)

A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
por: Raj, Pema, et al.
Publicado: (2021)

Brain, Liver, and Serum Salusin-alpha and -beta Alterations in Sprague-Dawley Rats with or without Metabolic Syndrome
por: Citil, Cihan, et al.
Publicado: (2014)

The Clinical Significance of Salusins in Systemic Sclerosis—A Cross-Sectional Study
por: Nowaczyk, Joanna, et al.
Publicado: (2023)

Cardioprotective effects of garcinol following myocardial infarction in rats with isoproterenol-induced heart failure
por: Li, Man, et al.
Publicado: (2020)

Inhibition of microRNA-146a attenuated heart failure in myocardial infarction rats
por: He, Junjie, et al.
Publicado: (2019)

Immunopharmacology of Post-Myocardial Infarction and Heart Failure Medications
por: Panahi, Mona, et al.
Publicado: (2018)

The Intersection of Type 2 Myocardial Infarction and Heart Failure
por: McCarthy, Cian P., et al.
Publicado: (2021)

Heart failure after myocardial infarction: incidence and predictors
por: Jenča, Dominik, et al.
Publicado: (2020)

Heart Failure After Right Ventricular Myocardial Infarction
por: Nägele, Matthias P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eb4fpmj2bi4eleafrtvhqntrns